Published in ACS Nano on February 23, 2010
Photoremovable protecting groups in chemistry and biology: reaction mechanisms and efficacy. Chem Rev (2012) 2.49
Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res (2011) 1.48
Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm (2013) 1.48
Photochemical mechanisms of light-triggered release from nanocarriers. Adv Drug Deliv Rev (2012) 1.40
Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev (2010) 1.29
Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. Cancer Res (2012) 1.24
Porphyrin-phospholipid liposomes permeabilized by near-infrared light. Nat Commun (2014) 1.20
Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv Healthc Mater (2011) 1.16
Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescence. ACS Nano (2013) 1.14
Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release. J Control Release (2011) 1.00
Gold nanostructures as a platform for combinational therapy in future cancer therapeutics. Cancers (Basel) (2011) 1.00
Low power, biologically benign NIR light triggers polymer disassembly. Macromolecules (2011) 0.99
Near-infrared light modulated photothermal effect increases vascular perfusion and enhances polymeric drug delivery. J Control Release (2011) 0.98
An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells. Small (2013) 0.95
Fluorinated graphene oxide; a new multimodal material for biological applications. Adv Mater (2013) 0.93
Hollow copper sulfide nanoparticle-mediated transdermal drug delivery. Small (2012) 0.92
Functionalized Gold Nanoparticles and Their Biomedical Applications. Nanomaterials (Basel) (2011) 0.90
Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev (2013) 0.90
Phase-shift, stimuli-responsive drug carriers for targeted delivery. Ther Deliv (2011) 0.90
The surprising in vivo instability of near-IR-absorbing hollow Au-Ag nanoshells. ACS Nano (2014) 0.89
Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials (2015) 0.87
Mesoporous magnetic gold "nanoclusters" as theranostic carrier for chemo-photothermal co-therapy of breast cancer. Theranostics (2014) 0.87
In vitro and in vivo mapping of drug release after laser ablation thermal therapy with doxorubicin-loaded hollow gold nanoshells using fluorescence and photoacoustic imaging. J Control Release (2013) 0.86
Highly efficient hierarchical micelles integrating photothermal therapy and singlet oxygen-synergized chemotherapy for cancer eradication. Theranostics (2014) 0.86
Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres. Part Fibre Toxicol (2014) 0.86
Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications. Chin Sci Bull (2012) 0.83
Dual imaging-guided photothermal/photodynamic therapy using micelles. Biomaterials (2014) 0.83
Specific tumor delivery of paclitaxel using glycolipid-like polymer micelles containing gold nanospheres. Biomaterials (2013) 0.83
Tumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model. Mol Imaging Biol (2013) 0.82
Nanoshell-mediated photothermal therapy can enhance chemotherapy in inflammatory breast cancer cells. Int J Nanomedicine (2015) 0.82
Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy. Pharm Res (2014) 0.82
Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy. Small (2014) 0.81
Mn-porphyrin conjugated Au nanoshells encapsulating doxorubicin for potential magnetic resonance imaging and light triggered synergistic therapy of cancer. Theranostics (2014) 0.81
Deoxycholate bile acid directed synthesis of branched Au nanostructures for near infrared photothermal ablation. Biomaterials (2015) 0.81
Combined cancer photothermal-chemotherapy based on doxorubicin/gold nanorod-loaded polymersomes. Theranostics (2015) 0.81
Research perspectives: gold nanoparticles in cancer theranostics. Quant Imaging Med Surg (2013) 0.80
Light-activatable gold nanoshells for drug delivery applications. AAPS PharmSciTech (2014) 0.80
Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells. Mol Ther Nucleic Acids (2015) 0.79
Targeted intracellular delivery of proteins with spatial and temporal control. Mol Pharm (2014) 0.78
Semimetal nanomaterials of antimony as highly efficient agent for photoacoustic imaging and photothermal therapy. Biomaterials (2015) 0.78
Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma. Theranostics (2016) 0.77
Development of individualized anti-metastasis strategies by engineering nanomedicines. Chem Soc Rev (2015) 0.77
Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.76
Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog. Org Biomol Chem (2015) 0.76
Gold Nanotheranostics: Proof-of-Concept or Clinical Tool? Nanomaterials (Basel) (2015) 0.76
Controlled Drug Release from Pharmaceutical Nanocarriers. Chem Eng Sci (2015) 0.76
Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy. Theranostics (2016) 0.75
Rap2b siRNA significantly enhances the anticancer therapeutic efficacy of adriamycin in a gold nanoshell-based drug/gene co-delivery system. Oncotarget (2017) 0.75
Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies. Int J Nanomedicine (2016) 0.75
Plasmon-Enhanced Photocleaving Dynamics in Colloidal MicroRNA-Functionalized Silver Nanoparticles Monitored with Second Harmonic Generation. Langmuir (2016) 0.75
Multifunctional organically modified silica nanoparticles for chemotherapy, adjuvant hyperthermia and near infrared imaging. Colloids Surf B Biointerfaces (2016) 0.75
Renal Clearable Organic Nanocarriers for Bioimaging and Drug Delivery. Adv Mater (2016) 0.75
Understanding the interactions between porphyrin-containing photosensitizers and polymer-coated nanoparticles in model biological environments. J Colloid Interface Sci (2015) 0.75
Hyperthermia using nanoparticles - Promises and pitfalls. Int J Hyperthermia (2016) 0.75
Laser-Triggered Small Interfering RNA Releasing Gold Nanoshells against Heat Shock Protein for Sensitized Photothermal Therapy. Adv Sci (Weinh) (2016) 0.75
Shape induced acid responsive heat triggered highly facilitated drug release by cube shaped magnetite nanoparticles. Biomicrofluidics (2016) 0.75
EGFR-targeted delivery of DOX-loaded Fe3O4@ polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapy. Int J Nanomedicine (2017) 0.75
Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats. Radiology (2016) 0.75
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Sci Rep (2016) 0.75
The Combination of Laser Therapy and Metal Nanoparticles in Cancer Treatment Originated From Epithelial Tissues: A Literature Review. J Lasers Med Sci (2016) 0.75
Hollow Au-Ag Nanoparticles Labeled Immunochromatography Strip for Highly Sensitive Detection of Clenbuterol. Sci Rep (2017) 0.75
Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy. Biomaterials (2017) 0.75
Observation of Metal Nanoparticles for Acoustic Manipulation. Adv Sci (Weinh) (2017) 0.75
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Endocytic recycling. Nat Rev Mol Cell Biol (2004) 10.87
Nanostructures in biodiagnostics. Chem Rev (2005) 9.96
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small (2005) 6.90
Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett (2007) 5.48
Monolayer-protected cluster molecules. Acc Chem Res (2000) 4.07
Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano (2007) 3.74
Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res (2008) 3.47
Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm (2005) 3.08
Locoregional cancer treatment with magnetic drug targeting. Cancer Res (2000) 3.05
Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design. J Am Chem Soc (2007) 2.82
Nanotechnologies for biomolecular detection and medical diagnostics. Curr Opin Chem Biol (2006) 2.74
Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther (2006) 2.48
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc (2008) 2.40
In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther (2008) 2.34
Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev (2008) 2.33
Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res (2009) 2.22
Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc (2008) 2.21
Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett (2009) 1.95
Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc (2007) 1.94
Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol Cancer Ther (2006) 1.86
Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett (2009) 1.86
Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano (2008) 1.80
Synthesis, characterization, and tunable optical properties of hollow gold nanospheres. J Phys Chem B (2006) 1.70
Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J Am Chem Soc (2009) 1.67
Beyond superquenching: hyper-efficient energy transfer from conjugated polymers to gold nanoparticles. Proc Natl Acad Sci U S A (2003) 1.64
Bifunctional Gold Nanoshells with a Superparamagnetic Iron Oxide-Silica Core Suitable for Both MR Imaging and Photothermal Therapy. J Phys Chem C Nanomater Interfaces (2007) 1.49
Carbon nanohorns as anticancer drug carriers. Mol Pharm (2005) 1.43
Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev (2008) 1.43
Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem (2007) 1.40
Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro. Mol Pharm (2005) 1.13
Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chemistry (2008) 1.11
Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin. Nanotechnology (2008) 0.95
Coming of age of lipid-based drug delivery systems. Adv Drug Deliv Rev (2004) 0.86
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44
Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med (2008) 7.13
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med (2009) 2.63
Flexible graphene films via the filtration of water-soluble noncovalent functionalized graphene sheets. J Am Chem Soc (2008) 2.62
Identification of new genetic risk variants for type 2 diabetes. PLoS Genet (2010) 2.62
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A (2013) 2.49
A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes (2004) 2.46
Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet (2005) 2.44
Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes (2004) 2.43
In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther (2008) 2.34
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res (2003) 2.25
Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res (2009) 2.22
Self-assembled graphene hydrogel via a one-step hydrothermal process. ACS Nano (2010) 2.13
Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials (2009) 2.13
Genetic association analysis using data from triads and unrelated subjects. Am J Hum Genet (2005) 2.06
A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc (2010) 2.02
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet (2010) 1.98
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet (2012) 1.91
Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev (2009) 1.90
Evaluation of coverage variation of SNP chips for genome-wide association studies. Eur J Hum Genet (2008) 1.89
Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev (2010) 1.87
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
Recurrent tissue-specific mtDNA mutations are common in humans. PLoS Genet (2013) 1.77
Exome sequencing generates high quality data in non-target regions. BMC Genomics (2012) 1.72
Design, synthesis and biological evaluation of a novel class of anticancer agents: anthracenylisoxazole lexitropsin conjugates. Bioorg Med Chem (2008) 1.71
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest (2011) 1.71
Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt (2005) 1.70
Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials (2009) 1.70
Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood (2010) 1.69
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy. Vaccine (2009) 1.68
Haemodynamics-driven developmental pruning of brain vasculature in zebrafish. PLoS Biol (2012) 1.65
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res (2011) 1.65
Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts. Mol Imaging (2004) 1.64
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability. Int J Radiat Oncol Biol Phys (2003) 1.62
Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors. J Control Release (2012) 1.61
Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61
Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res (2010) 1.60
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59
Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet (2011) 1.55
Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes (2004) 1.54
miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle (2010) 1.51
Near-infrared fluorescence optical imaging and tomography. Dis Markers (2004) 1.51
Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst (2010) 1.51
The age-dependent effect of anisometropia magnitude on anisometropic amblyopia severity. J AAPOS (2007) 1.50
Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res (2011) 1.48
Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma. Cancer Res (2011) 1.45
ATOM: a powerful gene-based association test by combining optimally weighted markers. Bioinformatics (2008) 1.44
Ultrahigh-rate supercapacitors based on eletrochemically reduced graphene oxide for ac line-filtering. Sci Rep (2012) 1.44
Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates. BMC Med Genet (2005) 1.44
Adjustment for local ancestry in genetic association analysis of admixed populations. Bioinformatics (2010) 1.44
Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine (Lond) (2010) 1.42
Controlled scalable synthesis of uniform, high-quality monolayer and few-layer MoS2 films. Sci Rep (2013) 1.41
Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey. Clin Rheumatol (2014) 1.41
National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China. Int J Rheum Dis (2013) 1.39
Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet (2013) 1.38
First-time failure rates of candidates for board certification: an educational outcome measure. Arch Ophthalmol (2008) 1.37
A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst (2013) 1.36
Imidazolopiperazines: hit to lead optimization of new antimalarial agents. J Med Chem (2011) 1.36
Sparganosis in mainland China. Int J Infect Dis (2010) 1.31
Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules (2007) 1.28
Assessing departure from Hardy-Weinberg equilibrium in the presence of disease association. Genet Epidemiol (2008) 1.27
Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers. J Acquir Immune Defic Syndr (2011) 1.27
Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction. Int J Cancer (2011) 1.27
Improved excitation light rejection enhances small-animal fluorescent optical imaging. Mol Imaging (2005) 1.25
Differential expression of components of the microRNA machinery during mouse organogenesis. Biochem Biophys Res Commun (2005) 1.25
Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res (2012) 1.24
Isolation and molecular characterization of equine H3N8 influenza viruses from pigs in China. Arch Virol (2009) 1.24
Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. Cancer Res (2012) 1.24
Longitudinal follow-up of hypermetropic children identified during preschool vision screening. J AAPOS (2010) 1.23
DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data. Bioinformatics (2010) 1.23
Native microflora in fresh-cut produce processing plants and their potentials for biofilm formation. J Food Prot (2013) 1.23
Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. ACS Nano (2012) 1.23
Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. J Med Chem (2012) 1.22
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Clin Cancer Res (2013) 1.21
The tallysomycin biosynthetic gene cluster from Streptoalloteichus hindustanus E465-94 ATCC 31158 unveiling new insights into the biosynthesis of the bleomycin family of antitumor antibiotics. Mol Biosyst (2006) 1.20
Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent. Bioconjug Chem (2004) 1.19
Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology (2013) 1.19
Link-based quantitative methods to identify differentially coexpressed genes and gene pairs. BMC Bioinformatics (2011) 1.19
Functional composite materials based on chemically converted graphene. Adv Mater (2011) 1.18
Strategy for encoding and comparison of gene expression signatures. Genome Biol (2007) 1.18
Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv Healthc Mater (2011) 1.16
Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease. Evid Based Complement Alternat Med (2012) 1.13
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Cancer Res (2008) 1.13
Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) (2011) 1.12
Near-infrared light triggers release of Paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity. Small (2010) 1.12
Direct liquefaction of Dunaliella tertiolecta for bio-oil in sub/supercritical ethanol-water. Bioresour Technol (2012) 1.12
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol (2010) 1.12
Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol (2006) 1.12
Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping. Invest Radiol (2007) 1.12
Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. J Nucl Med (2004) 1.08
Trehalose click polymers inhibit nanoparticle aggregation and promote pDNA delivery in serum. J Am Chem Soc (2006) 1.08
A pH-sensitive graphene oxide composite hydrogel. Chem Commun (Camb) (2010) 1.07
Theranostics with multifunctional magnetic gold nanoshells: photothermal therapy and t2* magnetic resonance imaging. Invest Radiol (2011) 1.07